Home
>
National Drug Code (NDC)
>
Premphase
Premphase - 0046-2575-12 - (conjugated estrogens and medroxyprogesterone acetate)
Drug Information of Premphase
| Product NDC: | 0046-2575 |
| Proprietary Name: | Premphase |
| Non Proprietary Name: | conjugated estrogens and medroxyprogesterone acetate |
| Active Ingredient(s): | & nbsp; conjugated estrogens and medroxyprogesterone acetate |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Premphase
| Product NDC: | 0046-2575 |
| Labeler Name: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020527 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130301 |
Package Information of Premphase
| Package NDC: | 0046-2575-12 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (0046-2575-12) > 1 KIT in 1 BLISTER PACK |
NDC Information of Premphase
| NDC Code | 0046-2575-12 |
| Proprietary Name | Premphase |
| Package Description | 1 BLISTER PACK in 1 CARTON (0046-2575-12) > 1 KIT in 1 BLISTER PACK |
| Product NDC | 0046-2575 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | conjugated estrogens and medroxyprogesterone acetate |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20130301 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
